Loading…
Lobbying Spend
—
Filings
6
Firms Hired
1
Active Period
2009–2010
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Lobbying in Support of HR 1548 the Pathways for Biologics Act, to promote patient safety while supporting the development of biologics.
Client expense: — · Firm income: $80,000
Matched citations: HR 1548
Lobbying in support of The Pathways for Biologics Act (HR1548), to promote patient safety while supporting the development of biologics, and related Senate legislation.
Client expense: — · Firm income: $75,000
Matched citations: HR1548
Lobbying in support of HR 1548 and S 726, the Pathways for Biologics Act, to promote patient safety while supporting the development of biologics.
Client expense: — · Firm income: —
Matched citations: HR 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Firm: THE RABEN GROUP
Lobbying in support of HR 1548 and S 726, the Pathways for Biologics Act, to promote patient safety while supporting the development of biologics.
Client expense: — · Firm income: —
Matched citations: S 726
Source: Senate LDA